NEWS
< back to news list

NanoGroup shareholders increase their involvement in the company

In the last days of July, the group announced further transactions related to the acquisition of company shares. Przemysław Mazurek, CEO, and Michał Lach increased their shares in NanoGroup.

According to the information provided in the current report by NanoGroup S.A., Michał Lach acquired another block of shares, which allowed him to increase his involvement by over 2 percent of the total number of votes in the group. Currently, this investor and its subsidiaries hold over 14 percent of the company’s shares.

The information about this purchase coincided with the announcement of the acquisition of a block of 16,000 shares by Przemysław Mazurek, who has been the chairman of the management board of NanoGroup S.A. since November 2022.

The funds raised will be used to develop research projects that NanoGroup is currently working on. The most important of these is the construction of a unique NanOX system for storing and regenerating organs collected for transplantation. In mid-July, the company reported a successful experiment of autotransplantation of a pig kidney, during which the effectiveness of this solution was confirmed. The success of the procedure was positively received by both the scientific community and was important in the market context.

NanoGroup, which has been listed on the Warsaw Stock Exchange since 2017, has thus fulfilled one of the important milestones, which was the basis for e-Capital, a company owned by Michał Lach, to acquire another block of shares. Another investor, Robert Dziubłowski, also increased his shares in the group.

Thank you for your trust.

Copyright © NanoGroup 2024

Prof. Tomasz Ciach

Founder, Member of the Management Board of NANOGROUP S.A.

Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.

Piotr Mierzejewski

Vice President of the Management Board of NANOGROUP S.A.

Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.